| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Comprehensive loss | -17,102 | -12,669 | ||
| Basic net loss per ordinary share (in dollars per share) | -0.31 | -0.23 | ||
| Diluted net loss per ordinary share (in dollars per share) | -0.31 | -0.23 | ||
| Weighted-average ordinary shares outstanding, basic (in shares) | 55,716,000 | 55,498,000 | ||
| Weighted-average ordinary shares outstanding, diluted (in shares) | 55,716,000 | 55,498,000 | ||
Connect Biopharma Holdings Ltd (CNTB)
Connect Biopharma Holdings Ltd (CNTB)